Mehmet Asim Bilen (Mehmet A Bilen)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 45

Top Venues

Cancer

Journal for immunotherapy of cancer

JCO precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F Mcdermott, Mehmet Asim Bilen, Mark Stein, Jeffrey Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael Hurwitz, David J Peace, David J Einstein, Paul J Catalano, Hans Hammers, Meredith M Regan
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A). Journal for immunotherapy of cancer 12 (4) (2024)
Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R K Singh, Elizabeth A Griffiths, Igor Puzanov, Erika Ruiz-Garcia, Diana Vilar-Compte, Ana I Cárdenas-Delgado, Rana R McKay, Taylor K Nonato, Archana Ajmera, Peter Paul Yu, Rajani Nadkarni, Timothy E O'Connor, Stephanie A Berg, Kim Ma, Dimitrios Farmakiotis, Kendra Vieira, Panos Arvanitis, Renee M Saliby, Chris Labaki, Amin H Nassar, Trisha M Wise-Draper, Olga Zamulko, Ningjing Li, Brianne E Bodin, Melissa K Accordino, Matthew Ingham, Monika Joshi, Hyma V Polimera, Leslie A Fecher, Christopher R Friese, James J Yoon, Blanche H Mavromatis, Jacqueline T Brown, Karen Russell, Rahul S Nanchal, Harpreet Singh, Lisa Tachiki, Feras A Moria, Gayathri Nagaraj, Kimberly Cortez, Saqib H Abbasi, Elizabeth M Wulff-Burchfield, Matthew Puc, Lisa B Weissmann, Padmanabh S Bhatt, Melissa G Mariano, Sanjay Mishra, Susan Halabi, Alicia Beeghly, Jeremy L Warner, Benjamin French, Mehmet Asim Bilen, null null
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer (2024)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F Mcdermott, Mehmet Asim Bilen, Mark Stein, Jeffrey Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael Hurwitz, David J Peace, David J Einstein, Paul J Catalano, Hans Hammers, Meredith M Regan
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A). Journal for immunotherapy of cancer 12 (4) (2024)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F Mcdermott, Mehmet Asim Bilen, Mark Stein, Jeffrey Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael Hurwitz, David J Peace, David J Einstein, Paul J Catalano, Hans Hammers, Meredith M Regan
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A). Journal for immunotherapy of cancer 12 (4) (2024)
Laura S Graham, Nicholas C Henderson, Olesia Kellezi, Clara Hwang, Pedro C Barata, Mehmet Asim Bilen, Deepak Kilari, Michael Pierro, Bicky Thapa, Abhishek Tripathi, George Mo, Matthew Kyle Labriola, Joseph J Park, Shoshana Rothstein, Rohan Garje, Vadim S Koshkin, Vaibhav G Patel, Tanya Barauskas Dorff, Andrew J Armstrong, Rana R McKay, Ajjai Alva, Michael Thomas Schweizer
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes. JCO precision oncology 8 (2024)
Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R K Singh, Elizabeth A Griffiths, Igor Puzanov, Erika Ruiz-Garcia, Diana Vilar-Compte, Ana I Cárdenas-Delgado, Rana R McKay, Taylor K Nonato, Archana Ajmera, Peter Paul Yu, Rajani Nadkarni, Timothy E O'Connor, Stephanie A Berg, Kim Ma, Dimitrios Farmakiotis, Kendra Vieira, Panos Arvanitis, Renee M Saliby, Chris Labaki, Amin H Nassar, Trisha M Wise-Draper, Olga Zamulko, Ningjing Li, Brianne E Bodin, Melissa K Accordino, Matthew Ingham, Monika Joshi, Hyma V Polimera, Leslie A Fecher, Christopher R Friese, James J Yoon, Blanche H Mavromatis, Jacqueline T Brown, Karen Russell, Rahul S Nanchal, Harpreet Singh, Lisa Tachiki, Feras A Moria, Gayathri Nagaraj, Kimberly Cortez, Saqib H Abbasi, Elizabeth M Wulff-Burchfield, Matthew Puc, Lisa B Weissmann, Padmanabh S Bhatt, Melissa G Mariano, Sanjay Mishra, Susan Halabi, Alicia Beeghly, Jeremy L Warner, Benjamin French, Mehmet Asim Bilen, null null
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer 130 (12) (2024)
Jimmy S Patel, Yena Woo, Amber Draper, Caroline S Jansen, Jennifer W Carlisle, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, Viraj A Master, Mehmet Asim Bilen, Mohammad K Khan, Michael C Lowe, Haydn T Kissick, Zachary S Buchwald, David C Qian
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. Journal for immunotherapy of cancer 12 (3) (2024)
Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R K Singh, Elizabeth A Griffiths, Igor Puzanov, Erika Ruiz-Garcia, Diana Vilar-Compte, Ana I Cárdenas-Delgado, Rana R McKay, Taylor K Nonato, Archana Ajmera, Peter Paul Yu, Rajani Nadkarni, Timothy E O'Connor, Stephanie A Berg, Kim Ma, Dimitrios Farmakiotis, Kendra Vieira, Panos Arvanitis, Renee M Saliby, Chris Labaki, Amin H Nassar, Trisha M Wise-Draper, Olga Zamulko, Ningjing Li, Brianne E Bodin, Melissa K Accordino, Matthew Ingham, Monika Joshi, Hyma V Polimera, Leslie A Fecher, Christopher R Friese, James J Yoon, Blanche H Mavromatis, Jacqueline T Brown, Karen Russell, Rahul S Nanchal, Harpreet Singh, Lisa Tachiki, Feras A Moria, Gayathri Nagaraj, Kimberly Cortez, Saqib H Abbasi, Elizabeth M Wulff-Burchfield, Matthew Puc, Lisa B Weissmann, Padmanabh S Bhatt, Melissa G Mariano, Sanjay Mishra, Susan Halabi, Alicia Beeghly, Jeremy L Warner, Benjamin French, Mehmet Asim Bilen, null null
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer 130 (12) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer (2024)
Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R K Singh, Elizabeth A Griffiths, Igor Puzanov, Erika Ruiz-Garcia, Diana Vilar-Compte, Ana I Cárdenas-Delgado, Rana R McKay, Taylor K Nonato, Archana Ajmera, Peter Paul Yu, Rajani Nadkarni, Timothy E O'Connor, Stephanie A Berg, Kim Ma, Dimitrios Farmakiotis, Kendra Vieira, Panos Arvanitis, Renee M Saliby, Chris Labaki, Amin H Nassar, Trisha M Wise-Draper, Olga Zamulko, Ningjing Li, Brianne E Bodin, Melissa K Accordino, Matthew Ingham, Monika Joshi, Hyma V Polimera, Leslie A Fecher, Christopher R Friese, James J Yoon, Blanche H Mavromatis, Jacqueline T Brown, Karen Russell, Rahul S Nanchal, Harpreet Singh, Lisa Tachiki, Feras A Moria, Gayathri Nagaraj, Kimberly Cortez, Saqib H Abbasi, Elizabeth M Wulff-Burchfield, Matthew Puc, Lisa B Weissmann, Padmanabh S Bhatt, Melissa G Mariano, Sanjay Mishra, Susan Halabi, Alicia Beeghly, Jeremy L Warner, Benjamin French, Mehmet Asim Bilen, null null
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer (2024)
Cecilia A Castellano, Tianyi Sun, Deepak Ravindranathan, Clara Hwang, Nino Balanchivadze, Sunny R K Singh, Elizabeth A Griffiths, Igor Puzanov, Erika Ruiz-Garcia, Diana Vilar-Compte, Ana I Cárdenas-Delgado, Rana R McKay, Taylor K Nonato, Archana Ajmera, Peter Paul Yu, Rajani Nadkarni, Timothy E O'Connor, Stephanie A Berg, Kim Ma, Dimitrios Farmakiotis, Kendra Vieira, Panos Arvanitis, Renee M Saliby, Chris Labaki, Amin H Nassar, Trisha M Wise-Draper, Olga Zamulko, Ningjing Li, Brianne E Bodin, Melissa K Accordino, Matthew Ingham, Monika Joshi, Hyma V Polimera, Leslie A Fecher, Christopher R Friese, James J Yoon, Blanche H Mavromatis, Jacqueline T Brown, Karen Russell, Rahul S Nanchal, Harpreet Singh, Lisa Tachiki, Feras A Moria, Gayathri Nagaraj, Kimberly Cortez, Saqib H Abbasi, Elizabeth M Wulff-Burchfield, Matthew Puc, Lisa B Weissmann, Padmanabh S Bhatt, Melissa G Mariano, Sanjay Mishra, Susan Halabi, Alicia Beeghly, Jeremy L Warner, Benjamin French, Mehmet Asim Bilen, null null
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study. Cancer 130 (12) (2024)
Laura S Graham, Nicholas C Henderson, Olesia Kellezi, Clara Hwang, Pedro C Barata, Mehmet Asim Bilen, Deepak Kilari, Michael Pierro, Bicky Thapa, Abhishek Tripathi, George Mo, Matthew Kyle Labriola, Joseph J Park, Shoshana Rothstein, Rohan Garje, Vadim S Koshkin, Vaibhav G Patel, Tanya Barauskas Dorff, Andrew J Armstrong, Rana R McKay, Ajjai Alva, Michael Thomas Schweizer
DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes. JCO precision oncology 8 (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A phase 1 study of acapatamab, a half-life extended, PSMA-targeting bispecific T-cell engager for metastatic castration-resistant prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Jimmy S Patel, Yena Woo, Amber Draper, Caroline S Jansen, Jennifer W Carlisle, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, Viraj A Master, Mehmet Asim Bilen, Mohammad K Khan, Michael C Lowe, Haydn T Kissick, Zachary S Buchwald, David C Qian
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. Journal for immunotherapy of cancer 12 (3) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Dylan J Martini, Katherine B Case, Derrik Gratz, Kathryn Pellegrini, Elizabeth Beagle, Thomas Schneider, Melad Dababneh, Bassel Nazha, Jacqueline T Brown, Shreyas S Joshi, Vikram M Narayan, Kenneth Ogan, Viraj A Master, Bradley C Carthon, Omer Kucuk, Lara R Harik, Mehmet Asim Bilen
PD-L1 and nectin-4 expression and genomic characterization of bladder cancer with divergent differentiation. Cancer (2024)
Jimmy S Patel, Yena Woo, Amber Draper, Caroline S Jansen, Jennifer W Carlisle, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, Viraj A Master, Mehmet Asim Bilen, Mohammad K Khan, Michael C Lowe, Haydn T Kissick, Zachary S Buchwald, David C Qian
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. Journal for immunotherapy of cancer 12 (3) (2024)
Joseph J Park, Shih-Chun A Chu, Jinju Li, Alicia Ali, Rana R McKay, Clara Hwang, Matthew Kyle Labriola, Albert Jang, Deepak Kilari, George Mo, Deepak Ravindranathan, Laura S Graham, Alexandra O Sokolova, Abhishek Tripathi, Amanda Pilling, Tanya Jindal, Aditya Ravindra, Frank Cameron Cackowski, Patrick L Sweeney, Bicky Thapa, Taylor S Amery, Elisabeth I Heath, Rohan Garje, Yousef Zakharia, Vadim S Koshkin, Mehmet Asim Bilen, Michael Thomas Schweizer, Pedro C Barata, Tanya Barauskas Dorff, Marcin P Cieslik, Ajjai S Alva, Andrew J Armstrong
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations. JCO precision oncology 8 (2024)
Joseph J Park, Shih-Chun A Chu, Jinju Li, Alicia Ali, Rana R McKay, Clara Hwang, Matthew Kyle Labriola, Albert Jang, Deepak Kilari, George Mo, Deepak Ravindranathan, Laura S Graham, Alexandra O Sokolova, Abhishek Tripathi, Amanda Pilling, Tanya Jindal, Aditya Ravindra, Frank Cameron Cackowski, Patrick L Sweeney, Bicky Thapa, Taylor S Amery, Elisabeth I Heath, Rohan Garje, Yousef Zakharia, Vadim S Koshkin, Mehmet Asim Bilen, Michael Thomas Schweizer, Pedro C Barata, Tanya Barauskas Dorff, Marcin P Cieslik, Ajjai S Alva, Andrew J Armstrong
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable Alterations. JCO precision oncology 8 (2024)
Tanya Barauskas Dorff, Lisa G Horvath, Karen A Autio, Alice Bernard-Tessier, Matthew B Rettig, Jean-Pascal H Machiels, Mehmet Asim Bilen, Martijn Paul Lolkema, Nabil Adra, Sylvie Rottey, Richard Greil, Nobuaki Matsubara, Daniel Shao-Weng Tan, Alvin S C Wong, Hiroji Uemura, Charlotte Lemech, Johannes Meran, Youfei Yu, Mukul Minocha, Mason McComb, Hweixian Leong Penny, Vinita Gupta, Xuguang Hu, Gabor Jurida, Hosein Kouros-Mehr, Margit M Janát-Amsbury, Tobias Eggert, Ben Tran
A Phase I Study of Acapatamab, a Half-life Extended, PSMA-Targeting Bispecific T-cell Engager for Metastatic Castration-Resistant Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (8) (2024)
Jimmy S Patel, Yena Woo, Amber Draper, Caroline S Jansen, Jennifer W Carlisle, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, Viraj A Master, Mehmet Asim Bilen, Mohammad K Khan, Michael C Lowe, Haydn T Kissick, Zachary S Buchwald, David C Qian
Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis. Journal for immunotherapy of cancer 12 (3) (2024)
Eric J Miller, Tracy L Rose, Benjamin L Maughan, Matthew I Milowsky, Mehmet Asim Bilen, Bradley C Carthon, Xin Gao, Suthee Rapisuwon, Qianqian Zhao, Menggang Yu, Neeraj Agarwal, Matthew D Galsky
Phase 2 trial of tremelimumab in patients with metastatic urothelial cancer previously treated with programmed death 1/programmed death ligand 1 blockade. Cancer 130 (9) (2024)
Jacqueline T Brown, Bassel Nazha, Mehmet Asim Bilen
Combined Programmed Death-Ligand 1 and MET Inhibition: Has Papillary Renal Cell Carcinoma MET Its Match? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, Christopher J Hoimes, Thomas W Flaig, Nataliya Mar, Helen H Moon, Terence W Friedlander, Rana R McKay, Mehmet Asim Bilen, Sandy Srinivas, Earle F Burgess, Chethan Ramamurthy, Saby George, Daniel M Geynisman, Sergio Bracarda, Delphine Borchiellini, Lionnel Geoffrois, Jose Pablo Maroto Rey, Christiano Ferrario, Anne-Sophie Carret, Yao Yu, Maria Guseva, Blanca Homet Moreno, Jonathan E Rosenberg
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Michael B Atkins, Opeyemi A Jegede, Naomi B Haas, David F McDermott, Mehmet Asim Bilen, Mark Stein, Jeffrey A Sosman, Robert Alter, Elizabeth R Plimack, Moshe C Ornstein, Michael Hurwitz, David J Peace, Sabina Signoretti, Thomas Denize, Alessia Cimadamore, Catherine J Wu, David A Braun, David Einstein, Paul J Catalano, Hans Hammers
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B). Journal for immunotherapy of cancer 11 (3) (2023)
Amir Ishaq Khan, Sarah P Psutka, Dattatraya H Patil, Gordon Hong, Milton A Williams, Mehmet Asim Bilen, Aarti Sekhar, Haydn T Kissick, Vikram M Narayan, Shreyas S Joshi, Kenneth Ogan, Viraj A Master
Sarcopenia and systemic inflammation are associated with decreased survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. Cancer 128 (11) (2022)
Jennifer Wilkinson Carlisle, Caroline S Jansen, Maria Andrea Cardenas, Ewelina Sobierajska, Adriana Moon Reyes, Rachel Greenwald, Luke Del Balzo, Nataliya Prokhnevska, Omer Kucuk, Bradley C Carthon, Patrick Connor Mullane, Adeboye Osunkoya, Deborah Baumgarten, Fares Hosseinzadeh, Scott Wilkinson, Ross Lake, Adam G Sowalsky, Yuan Liu, Viraj A Master, Mehmet Asim Bilen, Haydn T Kissick
Clinical outcome following checkpoint therapy in renal cell carcinoma is associated with a burst of activated CD8 T cells in blood. Journal for immunotherapy of cancer 10 (7) (2022)
Nizar M Tannir, Daniel C Cho, Adi Diab, Mario Sznol, Mehmet Asim Bilen, Arjun V Balar, Giovanni Grignani, Erika Puente, Lily Tang, David Chien, Ute Hoch, Arkopal Choudhury, Danni Yu, Sue L Currie, Mary A Tagliaferri, Jonathan Zalevsky, Arlene O Siefker-Radtke, Michael E Hurwitz
Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study. Journal for immunotherapy of cancer 10 (4) (2022)
Jacqueline T Brown, Yuan Liu, Julie M Shabto, Dylan Martini, Deepak Ravindranathan, Emilie Elise Hitron, Greta Anne Russler, Sarah Caulfield, Lauren Yantorni, Shreyas Subhash Joshi, Haydn Kissick, Kenneth Ogan, Bassel Nazha, Bradley C Carthon, Omer Kucuk, Wayne B Harris, Viraj A Master, Mehmet Asim Bilen
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors. Journal for immunotherapy of cancer 9 (7) (2022)
Dylan J Martini, Subir Goyal, Yuan Liu, Sean T Evans, T Anders Olsen, Katherine Case, Benjamin L Magod, Jacqueline T Brown, Lauren Yantorni, Greta Anne Russler, Sarah Caulfield, Jamie M Goldman, Bassel Nazha, Wayne B Harris, Haydn T Kissick, Viraj A Master, Omer Kucuk, Bradley C Carthon, Mehmet Asim Bilen
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. The oncologist 26 (10) (2021)
Michelle I Higgins, Dylan J Martini, Dattatraya H Patil, Reza Nabavizadeh, Sean Steele, Milton Williams, Shreyas S Joshi, Vikram M Narayan, Aarti Sekhar, Sarah P Psutka, Kenneth Ogan, Mehmet Asim Bilen, Viraj A Master
Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma. Cancer 127 (12) (2021)
Dylan J Martini, Yuan Liu, Viraj A Master, Robert Donald Harvey, Mehmet Asim Bilen
Reply to Body fat indices and survival in immunotherapy-treated patients with cancer. Cancer 126 (13) (2020)
Julie M Shabto, Dylan J Martini, Yuan Liu, Deepak Ravindranathan, Jacqueline Brown, Emilie E Hitron, Greta A Russler, Sarah Caulfield, Haydn Kissick, Mehrdad Alemozaffar, Kenneth Ogan, Wayne B Harris, Viraj A Master, Omer Kucuk, Bradley C Carthon, Mehmet Asim Bilen
Novel risk group stratification for metastatic urothelial cancer patients treated with immune checkpoint inhibitors. Cancer medicine 9 (8) (2020)
Bassel Nazha, Mehmet Asim Bilen
Circulating interleukin 6, androgen deprivation therapy, and fatigue in prostate cancer: Is inflammation the link? Cancer 127 (9) (2020)
Bradley Alexander McGregor, Matthew T Campbell, Wanling Xie, Subrina Farah, Mehmet Asim Bilen, Andrew L Schmidt, Guru P Sonpavde, Kerry L Kilbridge, Atish D Choudhury, Amir Mortazavi, Amishi Y Shah, Aradhana M Venkatesan, Glenn J Bubley, Arlene O Siefker-Radtke, Rana R McKay, Toni K Choueiri
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies. Cancer 127 (6) (2020)
Mehmet Asim Bilen, Julie M Shabto, Dylan J Martini, Yuan Liu, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn Kissick, Bradley C Carthon, Walid L Shaib, Olatunji B Alese, Conor E Steuer, Christina Wu, David H Lawson, Ragini Kudchadkar, Viraj A Master, Bassel El-Rayes, Suresh S Ramalingam, Taofeek K Owonikoko, R Donald Harvey
Sites of metastasis and association with clinical outcome in advanced stage cancer patients treated with immunotherapy. BMC cancer 19 (1) (2019)
Dylan J Martini, Meredith R Kline, Yuan Liu, Julie M Shabto, Milton A Williams, Amir Ishaq Khan, Colleen Lewis, Hannah Collins, Mehmet Akce, Haydn T Kissick, Bradley C Carthon, Walid L Shaib, Olatunji B Alese, Rathi N Pillai, Conor E Steuer, Christina S Wu, David H Lawson, Ragini R Kudchadkar, Bassel F El-Rayes, Suresh R Ramalingam, Taofeek K Owonikoko, Robert Donald Harvey, Viraj A Master, Mehmet Asim Bilen
Adiposity may predict survival in patients with advanced stage cancer treated with immunotherapy in phase 1 clinical trials. Cancer 126 (3) (2019)
Guru Sonpavde, Neeraj Agarwal, Gregory Russell Pond, Rebecca J Nagy, Roberto H Nussenzveig, Andrew W Hahn, Oliver Sartor, Theodore Stewart Gourdin, Lakshminarayanan Nandagopal, Elisa M Ledet, Gurudatta Naik, Andrew J Armstrong, Jue Wang, Mehmet Asim Bilen, Shilpa Gupta, Petros Grivas, Sumanta Kumar Pal, Richard B Lanman, AmirAli Talasaz, Michael B Lilly
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer. Cancer 125 (9) (2019)
Mehmet Asim Bilen, Haydn T Kissick, Robert Donald Harvey
Reply to Tumor-associated macrophages: "Good cop-bad cop". Cancer 125 (11) (2019)
Ali Raza Khaki, Ang Li, Leonidas N Diamantopoulos, Mehmet Asim Bilen, Victor Santos, John Esther, Rafael Morales-Barrera, Michael Devitt, Ariel Nelson, Christopher J Hoimes, Evan Shreck, Hussein A Assi, Benjamin A Gartrell, Alex Sankin, Alejo Rodriguez-Vida, Mark Lythgoe, David James Pinato, Alexandra Drakaki, Monika Joshi, Pedro Isaacsson Velho, Noah Hahn, Sandy Liu, Lucia Alonso Buznego, Ignacio Duran, Marcus Moses, Jayanshu Jain, Jure Murgic, Praneeth Baratam, Pedro Barata, Abhishek Tripathi, Yousef Zakharia, Matthew D Galsky, Guru Sonpavde, Evan Y Yu, Veena Shankaran, Gary H Lyman, Petros D Grivas
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors. Cancer 126 (6) (2019)
Dylan J Martini, Yuan Liu, Julie M Shabto, Colleen Lewis, Meredith R Kline, Hannah Collins, Mehmet Akce, Haydn T Kissick, Bradley C Carthon, Walid L Shaib, Olatunji B Alese, Rathi N Pillai, Conor E Steuer, Christina S Wu, David H Lawson, Ragini R Kudchadkar, Viraj A Master, Bassel F El-Rayes, Suresh S Ramalingam, Taofeek K Owonikoko, R Donald Harvey, Mehmet Asim Bilen
Clinical outcomes of advanced stage cancer patients treated with sequential immunotherapy in phase 1 clinical trials. Investigational new drugs 37 (6) (2019)
Deepak Ravindranathan, Emilie Elise Hitron, Greta Anne Russler, Yue Xue, Mehmet Asim Bilen
Metastatic Prostate Cancer Manifesting as Cholestatic Jaundice: A Case Report and Review of the Literature. Case reports in oncological medicine 2018 (2018)
Mehmet Asim Bilen, Dylan J Martini, Yuan Liu, Colleen Lewis, Hannah H Collins, Julie M Shabto, Mehmet Akce, Haydn T Kissick, Bradley C Carthon, Walid L Shaib, Olatunji B Alese, Rathi N Pillai, Conor E Steuer, Christina S Wu, David H Lawson, Ragini R Kudchadkar, Bassel F El-Rayes, Viraj A Master, Suresh R Ramalingam, Taofeek K Owonikoko, R Donald Harvey
The prognostic and predictive impact of inflammatory biomarkers in patients who have advanced-stage cancer treated with immunotherapy. Cancer 125 (1) (2018)

Mehmet Asim Bilen.css-eqlu8i{font-size:small;padding-left:4px;} (Mehmet A Bilen)

Publication Activity (10 Years)

Top Topics

Top Venues

Mehmet Asim Bilen (Mehmet A Bilen)